Kevin Lee - Aug 27, 2021 Form 4 Insider Report for BICYCLE THERAPEUTICS plc (BCYC)

Role
Chief Executive Officer, Director
Signature
/s/ Lee Kalowski, Attorney-in-Fact
Stock symbol
BCYC
Transactions as of
Aug 27, 2021
Transactions value $
-$301,695
Form type
4
Date filed
8/31/2021, 05:29 PM
Previous filing
Jul 27, 2021
Next filing
Sep 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCYC Ordinary Shares Options Exercise $25.3K +1.81K +0.74% $14.00 247K Aug 27, 2021 Direct
transaction BCYC Ordinary Shares Sale -$65.1K -1.81K -0.73% $36.02 245K Aug 27, 2021 Direct F1, F2
transaction BCYC Ordinary Shares Options Exercise $146K +10.4K +4.25% $14.00 256K Aug 31, 2021 Direct
transaction BCYC Ordinary Shares Sale -$361K -9.95K -3.9% $36.23 246K Aug 31, 2021 Direct F1, F3
transaction BCYC Ordinary Shares Sale -$47.2K -1.27K -0.52% $37.08 244K Aug 31, 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCYC Stock Option (right to buy) Options Exercise $0 -1.81K -0.53% $0.00 340K Aug 27, 2021 Ordinary Shares 1.81K $14.00 Direct F5
transaction BCYC Stock Option (right to buy) Options Exercise $0 -10.4K -3.07% $0.00 329K Aug 31, 2021 Ordinary Shares 10.4K $14.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.20 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.86 inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.58 inclusive.
F5 This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant.